Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan
Kurs
+2,12%
Likviditet
45,9 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2026-02-19 | 14:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-16 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-24 | - | Årsstämma |
| 2025-04-24 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-19 | 14:00 | Bokslutskommuniké 2024 |
| 2024-10-23 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-16 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | X-dag ordinarie utdelning BIOT 1.60 SEK |
| 2024-04-25 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-25 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | X-dag ordinarie utdelning BIOT 1.60 SEK |
| 2023-04-27 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-02 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | X-dag ordinarie utdelning BIOT 1.55 SEK |
| 2022-04-28 | - | Årsstämma |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-11 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | X-dag ordinarie utdelning BIOT 1.50 SEK |
| 2021-04-28 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-12 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-05 | - | X-dag ordinarie utdelning BIOT 0.00 SEK |
| 2020-06-04 | - | Årsstämma |
| 2020-04-28 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-07 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Extra Bolagsstämma 2019 |
| 2019-11-05 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-16 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-25 | - | X-dag ordinarie utdelning BIOT 1.50 SEK |
| 2019-04-24 | - | Årsstämma |
| 2019-04-24 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-07 | - | Bokslutskommuniké 2018 |
| 2018-11-06 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-27 | - | X-dag ordinarie utdelning BIOT 1.40 SEK |
| 2018-04-26 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-11-02 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-18 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-28 | - | X-dag ordinarie utdelning BIOT 1.25 SEK |
| 2017-04-27 | - | Årsstämma |
| 2017-02-09 | - | Bokslutskommuniké 2016 |
| 2016-11-10 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-11 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-29 | - | X-dag ordinarie utdelning BIOT 1.00 SEK |
| 2016-04-29 | - | X-dag bonusutdelning BIOT 0.25 |
| 2016-04-28 | - | Årsstämma |
| 2016-04-28 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-11 | - | Bokslutskommuniké 2015 |
| 2015-10-30 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-29 | - | X-dag ordinarie utdelning BIOT 0.75 SEK |
| 2015-04-28 | - | Årsstämma |
| 2015-04-28 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-10-30 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-14 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-29 | - | X-dag ordinarie utdelning BIOT 0.60 SEK |
| 2014-04-28 | - | Årsstämma |
| 2014-04-28 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-13 | - | Bokslutskommuniké 2013 |
| 2013-10-25 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-15 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-26 | - | X-dag ordinarie utdelning BIOT 0.50 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-12 | - | Bokslutskommuniké 2012 |
| 2012-10-26 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-17 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-27 | - | X-dag ordinarie utdelning BIOT 0.40 SEK |
| 2012-04-26 | - | Årsstämma |
| 2012-04-26 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-09 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-17 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | - | X-dag ordinarie utdelning BIOT 0.25 SEK |
| 2011-04-27 | - | Årsstämma |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-10 | - | Bokslutskommuniké 2010 |
| 2010-10-26 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-13 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-30 | - | X-dag ordinarie utdelning BIOT 0.20 SEK |
| 2010-04-29 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-11 | - | Bokslutskommuniké 2009 |
| 2009-10-27 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-14 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-28 | - | X-dag ordinarie utdelning BIOT 0.20 SEK |
| 2009-04-27 | - | Årsstämma |
| 2009-04-27 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Uppsala, Sweden – 18 July, 2023 – The Annual General Meeting of Biotage AB (publ) (“Biotage”) resolved on June 4, 2020 to adopt a long-term incentive plan (“LTIP 2020”) which has now expired and for this reason, a total of 52,347 ordinary shares are transferred free of charge to the participants in LTIP 2020. To cover tax costs associated with LTIP 2020, some participants intend to sell a number of shares through Danske Bank A/S on Nasdaq Stockholm and, correspondingly, the company transfers a maximum of 17,960 ordinary shares to cover social contribution costs associated with LTIP 2020 which is expected to take place during the period 18 July 2023 until 24 July 2023, at a price within the registered price range at the relevant time. In order to enable the transfer of own ordinary shares, the Board of Directors has resolved to reclassify 70,307 class C shares into ordinary shares in accordance with the reclassification provision in the company’s Articles of Association.
The company’s holding of own class C shares previously amounted to 729,817. Following the conversion of 70,307 class C shares and transfer of the corresponding number of ordinary shares, Biotage will hold 659,510 own class C shares.
This information was submitted for publication, through the agency of the contact persons set out above, at 13.00 CEST on 18 July 2023.
Website: www.biotage.com
About Biotage
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs appr. 700 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Website: www.biotage.com